MARKET

PCRX

PCRX

Pacira Biosciences Inc
NASDAQ
27.60
+0.10
+0.36%
Opening 10:48 11/29 EST
OPEN
27.65
PREV CLOSE
27.50
HIGH
28.14
LOW
27.60
VOLUME
42.49K
TURNOVER
0
52 WEEK HIGH
49.37
52 WEEK LOW
25.93
MARKET CAP
1.28B
P/E (TTM)
475.86
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at PCRX last week (1120-1124)?
Weekly Report · 2d ago
Declining Stock and Decent Financials: Is The Market Wrong About Pacira BioSciences, Inc. (NASDAQ:PCRX)?
Pacira biosciences's roe of 0.8% is a good sign for a company's ability to reinvest its profits. The company made a profit of  0.08% in the 12 months to september 2013. Pacira biosciences has a return on equity of return on equity of 0.9%. The stock has been down 28% since the beginning of the year. But the company has a good roe, and the stock could be worth a look.
Simply Wall St · 4d ago
Pacira Biosciences Inc: [Cover]SEC-generated letter
Press release · 6d ago
Pacira Biosciences Inc: Correspondence
Press release · 6d ago
Weekly Report: what happened at PCRX last week (1113-1117)?
Weekly Report · 11/20 09:12
Pacira Biosciences Inc: Report of proposed sale of securities
Press release · 11/13 17:00
Pacira (PCRX) Gets FDA Nod for Exparel's Label Expansion
NASDAQ · 11/13 15:10
Weekly Report: what happened at PCRX last week (1106-1110)?
Weekly Report · 11/13 09:11
More
About PCRX
Pacira BioSciences, Inc. is a holding company for Pacira Pharmaceuticals, Inc. The Company is engaged in advancing a pipeline of products across a range of therapeutic areas that include acute postsurgical pain; acute and chronic osteoarthritis (OA), pain, spasticity and stellate ganglion block. The Company is developing interventions to address debilitating conditions involving the sympathetic nervous system. The Company's non-opioid treatments include EXPAREL (bupivacaine liposome injectable suspension), which is a long-acting, local analgesic for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), which is an extended-release, intra-articular (IA), corticosteroid injection indicated for OA knee pain, and Iovera, which is a novel handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

Webull offers Pacira Biosciences Inc stock information, including NASDAQ: PCRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PCRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PCRX stock methods without spending real money on the virtual paper trading platform.